NEW DATA: Unlocking Treg Functional Pathways to Drive Therapeutic Innovation
- Investigating the key drivers and surface molecules required for Treg functionality
- Highlighting necessity for the cGAS/STING/type I IFN axis for induction of tolerance (via Treg induction) by antigen-loaded PLGA nanoparticles
- Exploring novel therapies that have leveraged these mechanisms of action to regulate the immune response